Columbus Circle Investors’s Charles River Laboratories CRL Stock Holding History

Columbus Circle Investors’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-22,390	Closed	-$2.42M	–	191
2017 Q3	$2.42M	Sell	22,390 -17,256	-44%	-$1.77M	0.04%	216
2017 Q2	$4.01M	Sell	39,646 -36,078	-48%	-$3.32M	0.07%	174
2017 Q1	$6.81M	Buy	75,724 +47,703	+170%	+$4.05M	0.1%	173
2016 Q4	$2.13M	Sell	28,021 -79,645	-74%	-$6.05M	0.03%	213
2016 Q3	$8.97M	Buy	107,666 +25,744	+31%	+$2.16M	0.1%	172
2016 Q2	$6.75M	Buy	+81,922	New	+$6.75M	0.07%	197
2014 Q2	–	Sell	-209,220	Closed	-$12.6M	–	278
2014 Q1	$12.6M	Buy	209,220 +121,349	+138%	+$7.07M	0.08%	198
2013 Q4	$4.66M	Buy	+87,871	New	+$4.41M	0.03%	252

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Columbus Circle Investors's CRL Position: Q4 2017 in Review

Columbus Circle Investors sold out of Charles River Laboratories (CRL) in Q4 2017, closing a stake of 22,390 shares — an estimated $2.42M sold.

Columbus Circle Investors first reported a position in CRL in Q4 2013 and held it in 8 quarters. The position peaked at $12.6M in Q1 2014. 339 funds tracked by Wall St. Rank hold CRL as of Q4 2017.

Columbus Circle Investors reported no remaining Charles River Laboratories position as of Q4 2017 after selling out during the quarter.
Columbus Circle Investors sold 22,390 Charles River Laboratories shares in Q4 2017, an estimated $2.42M.
Columbus Circle Investors first reported a position in Charles River Laboratories in Q4 2013 and held it in 8 quarters.
Columbus Circle Investors's Charles River Laboratories position peaked at $12.6M in Q1 2014.
339 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2017.

Based on Columbus Circle Investors's 13F filing for Q4 2017, filed 2 Feb 2018.